Patent · US Active

Polynucleotides encoding antibodies or antigen binding fragments thereof that bind pseudomonas perv

US11203633B2 · kind B2 · utility

1Cited by

58References

25Claims

0Family size

Assignee

MedImmune Limited · US

Inventors

Antonio Digiandomenico · Gaithersburg, US
Paul Warrener · Seattle, US
Charles K. Stover · Gaithersburg, US
Bret Sellman · Rochester, US
Ralph Minter · Cambridge, GB
Sandrine Guillard · Cambridge, GB
Steven Rust · Cambridge, GB
Mladen Tomich · New York, US
Vignesh Venkatraman · Cambridge, GB
Reena Varkey · Gaithersburg, US
Li Peng · Gaithersburg, US
Melissa Damschroder · Gaithersburg, US
Partha S. Chowdhury · Gaithersburg, US
Nazzareno Dimasi · Gaithersburg, US
Ryan Fleming · Gaithersburg, US
Binyam Bezabeh · Gaithersburg, US
Changshou Gao · Potomac, US
Godfrey Jonah Anderson Rainey · Gaithersburg, US
Cuihua Gao · Gaithersburg, US

Key dates

Filing date	Feb 13, 2020
Grant date	Dec 21, 2021
Priority date	—
Expiry date	Feb 13, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This disclosure relates to polynucleotides encoding antibodies or antigen binding fragments thereof that bind to Pseudomonas PcrV as well as vectors and host cells comprising the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.